Article
<i>L</i> -5-[11C]-glutamine PET of Breast Cancer: Kinetic Analysis in Mouse Models to Evaluate Glutamine Metabolism
2026-07-03
Abstract excerpt
<h4>Background</h4> Glutamine addiction is a hallmark of aggressive tumors, yet glutaminase (GLS1) inhibitor CB-839 showed disappointing anti-tumor efficacy in clinical trials. L -5-[¹¹C]-glutamine ([¹¹C]glutamine) PET enables non-invasive assessment of glutamine metabolism in vivo , providing a tool to test mechanistic hypotheses, and identify tumors likely to respond to GLS1 inhibition: focusing on compartm...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- baf5babd-e4e0-55ac-85d5-7bad13dab0dd
- DOI
- 10.64898/2026.07.02.736194
